ADHD Drug Shortage Could Worsen After Arrests Of 2 Telehealth Executives, CDC Warns

TOPLINE The arrests of two executives of a large telehealth medication company may worsen an almost two-year ADHD medication shortage and disrupt the care of upwards of 50,000 patients across the country, but the CDC warns against seeking treatment from the illegal drug market as an alternative.

KEY FACTS

Following the Thursday arrests of two telehealth executives who were working with the company Done Global Inc., the Centers for Disease Control and Prevention issued a health advisory warning the U.S. attention-deficit/hyperactivity disorder (ADHD) medication shortage may worsen.